CTI is the institute layer. Regenemm is the product layer.
CTI develops the education, clinical reasoning, and governance context. Regenemm applies that work to real documentation and care coordination workflows.
Built around the clinical communication gap
Regenemm is designed for the information that must move after a consultation: notes, letters, patient summaries, education, and structured records.
The clinical judgement stays with clinicians. The platform supports documentation, coordination, verification, and patient clarity.
Where to go next
Use CTI to understand the research, education, and governance thinking. Use Regenemm.com for the product, demo, trust center, platform capabilities, and resources.
From institute thinking to shared transparency
Regenemm turns clinical conversations into structured, consent-aware, auditable healthcare information. Specialist spokes capture clinical context and generate outputs; the Hub governs identity, consent, persistence, entitlements, distribution, telemetry and compliance evidence.
Regenemm Hub
The secure control plane for identity, consent, audit evidence, exports, persistence, routing and compliance controls.
Clinical spokes
Specialist applications that capture context, support role-specific workflows and generate structured clinical outputs.
Regenemm Voice
The clinical AI gateway for voice capture, transcription, summarisation, patient-facing summaries, structured documentation and care-team communication.
Shared transparency
The right clinical information, to the right people, at the right time, with consent and auditability underneath.
Verification and review
Regenemm is built around transcript-checked verification, human review, and accountable clinical workflow support.
No evidence, not done
Trust is treated as an engineering requirement across identity, access, audit trails, PHI protection and operational evidence.
Clinician-in-the-loop
Regenemm supports clinical judgement; it does not replace it. Human review, escalation and accountability remain central.
Clinical validation pathway
Human ethics preparation, participant consent materials, ISO 14971-style risk management and systematic evidence review are being used to support responsible clinical evaluation.
International trademark protection
Regenemm® and the Regenemm logo are protected internationally through Madrid Protocol trademark coverage across jurisdictions including Japan, Canada, the United Kingdom, Europe, the United States, New Zealand and South Africa.